Showing results (1-10 of 14) with videos related to
Sort By:
Pageof 2
European Journal of Immunology|April 23, 2009
Mice deficient in stem cell antigen-1 (Sca1, Ly-6A/E) develop normal primary and memory CD4+ and CD8+ T-cell responses to virus infectionJason K Whitmire, Boreth Eam, J Lindsay WhittonPlos Pathogens|April 12, 2008
Tentative T cells: memory cells are quick to respond, but slow to divideJason K Whitmire, Boreth Eam, J Lindsay WhittonJournal of Immunology (Baltimore, Md. : 1950)|July 10, 2007
Direct interferon-gamma signaling dramatically enhances CD4+ and CD8+ T cell memoryJason K Whitmire, Boreth Eam, Nicola Benning, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 6, 2008
Increasing the CD4+ T cell precursor frequency leads to competition for IFN-gamma thereby degrading memory cell quantity and qualityJason K Whitmire, Nicola Benning, Boreth Eam, et al.Applied and Environmental Microbiology|November 24, 2006
Vertical transmission of diverse microbes in the tropical sponge Corticium spKoty H Sharp, Boreth Eam, D John Faulkner, et al.Traffic (Copenhagen, Denmark)|July 7, 2005
Akt regulates the subcellular localization of the Rab27a-binding protein JFC1 by phosphorylationJennifer L Johnson, Sandrine Pacquelet, William S Lane, et al.Journal of Neuroimmunology|October 30, 2007
Myelin oligodendrocyte glycoprotein peptide-induced experimental allergic encephalomyelitis and T cell responses are unaffected by immunoproteasome deficiencyRicardo F Frausto, Stephen J Crocker, Boreth Eam, et al.Journal of Immunology (Baltimore, Md. : 1950)|October 23, 2013
Differential T cell responses to residual viral antigen prolong CD4+ T cell contraction following the resolution of infectionIchiro Misumi, Mehrdad Alirezaei, Boreth Eam, et al.Organic Letters|August 19, 2020
Strategic Diastereoselective C1 Functionalization in the Aza-Rocaglamide Scaffold toward Natural Product-Inspired eIF4A InhibitorsChristian Nilewski, Theodore D Michels, Alan X Xiang, et al.Frontiers in Oncology|December 13, 2021
Zotatifin, an eIF4A-Selective Inhibitor, Blocks Tumor Growth in Receptor Tyrosine Kinase Driven TumorsAdina Gerson-Gurwitz, Nathan P Young, Vikas K Goel, et al.Pageof 2